Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women
Condition(s):Breast CancerLast Updated:April 24, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:April 24, 2015Completed
Condition(s):Metastatic Breast Cancer; ER+ Breast Cancer; Advanced Breast CancerLast Updated:October 27, 2023Recruiting
Condition(s):Breast CancerLast Updated:March 13, 2012Completed
Condition(s):Metastatic Breast CancerLast Updated:June 15, 2016Unknown status
Condition(s):NeoplasmsLast Updated:August 21, 2015Unknown status
Condition(s):Breast CancerLast Updated:January 2, 2017Unknown status
Condition(s):Breast CancerLast Updated:March 1, 2024Recruiting
Condition(s):Metastatic Breast CancerLast Updated:December 22, 2020Unknown status
Condition(s):Breast CancerLast Updated:February 13, 2024Terminated
Condition(s):Breast CancerLast Updated:May 19, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.